Pfizer and BioNTech About to Sign the Biggest Vaccine Supply Deal Ever: Why It's Great News for Investors
The orders for Pfizer (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) COVID-19 vaccine keep flowing in. So far, the two partners have secured supply agreements with the European Union totaling 600 million doses, including one signed just last week for 100 million doses. Pfizer and BioNTech are supplying 300 million doses to the U.S. In addition to these two big supply deals, Pfizer and BioNTech have agreements in place with several other countries including Canada, Japan, and the U.K.
And now it looks like Pfizer and BioNTech are at the threshold of signing the biggest vaccine supply deal ever. Here's what makes this especially great news for investors in these two stocks.
Image source: Getty Images.
Source Fool.com
